JUL 24, 2020 12:46 PM PDT

A New Biomarker Candidate for Cancer Diagnostics

WRITTEN BY: Jasper Cantrell

One of the best tools in the fight against cancer is diagnostics. In 2018, colorectal cancer was the second most lethal cancer in the world due to a lack of effective diagnostic tools. It is often not caught until it reaches later stages, where treatments are less impactful.

Modern diagnostics identify diseases and their severity by following biomarkers. Biomarkers are genes, proteins, or other factors with abnormal expression levels in diseases compared to healthy tissues. In cancer, this type of diagnostic method has become popular in the research. Future diagnostic tools will be able to identify a disease and identify the best way to treat it.

A recent screening study in colorectal cancer found that the protein transcobalamin 1 is abnormally expressed. This protein has various cellular roles and has been found in high levels in several types of cancer. A team from the Hebei Medical University in China decided to investigate this biomarker candidate to diagnose colorectal cancer.  

The team began by confirming that transcobalamin 1 is overexpressed in colorectal patients versus healthy tissue. Statistical analysis revealed it was strongly associated with a poor prognosis and late stages of colorectal cancer. These observations indicate transcobalamin 1 may act as a good diagnostic marker for colorectal cancer. On top of that, there was a distinct decrease in transcobalamin 1 levels after being treated with chemotherapy.

The team then examined how transcobalamin 1 acted as a tumor promoter. Computational analysis showed that many proteins involved in pro-tumor signaling were upregulated alongside transcobalamin 1. They could not further elaborate, however.

In this study, transcobalamin 1 proved to be a strong candidate for a diagnostic biomarker. It was clearly overexpressed in colorectal cancers, and this expression decreased upon undergoing chemotherapy showing it has potential as a chemosensitivity marker. How it works as a pro-tumor factor remains unknown, however.

The team concludes, “Taken together, we conclude that TCN1 expression is significantly overexpressed in colon cancer and is correlated with advanced pathological features. TCN1 may be a predictor of prognosis and a potential biomarker for predicting chemosensitivity.”

Sources: Nature Scientific Reports, U.S. Food and Drug Administration

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
APR 14, 2021
Cancer
Fighting back against medulloblastoma with naturally-occurring compound
APR 14, 2021
Fighting back against medulloblastoma with naturally-occurring compound
Renewed hope for young children with medulloblastoma comes in the form of a research paper published from the Queen Mary ...
MAY 03, 2021
Cardiology
Task Force IDs 7 Costly Medical Procedures With No Benefit
MAY 03, 2021
Task Force IDs 7 Costly Medical Procedures With No Benefit
Researchers have identified a surprising number of health screens that are given to patients who may not need them. Thes ...
MAY 20, 2021
Clinical & Molecular DX
Ovarian Cancer Screening More Beneficial for Early Cancer Detection
MAY 20, 2021
Ovarian Cancer Screening More Beneficial for Early Cancer Detection
A UK-based research study has shown that while ovarian cancer screening is beneficial for detecting cancers earlier, it ...
MAY 24, 2021
Health & Medicine
How do healthcare insurance disruptions affect access and affordability to care?
MAY 24, 2021
How do healthcare insurance disruptions affect access and affordability to care?
Have you ever been in between health insurance coverage and pushed off receiving healthcare that you needed? According t ...
MAY 27, 2021
Microbiology
Some Microbes May Protect the Gut From Chemo's Harmful Effects
MAY 27, 2021
Some Microbes May Protect the Gut From Chemo's Harmful Effects
The microbes in our gut can influence our physiology in many ways. Some gut microbes have a positive impact on human hea ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
Loading Comments...